Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation related application

50:

• The method of claim 49, wherein the one or more conditions are associated with systemic sympathetic hyperactivity of the patient.

51:

• The method of claim 49, wherein the one or more conditions are associated with central sympathetic overactivity, and wherein delivering the neuromodulation therapy to the target location reduces the central sympathetic overactivity of the patient.

53:

• The method of claim 49, wherein the one or more nerves innervate the sex organs or genitalia.

54:

• The method of claim 49, wherein the blood vessel is an inferior mesenteric artery of the patient.

55:

• The method of claim 54, wherein the one or more nerves encircle the inferior mesenteric artery.

56:

• The method of claim 49, wherein the neuromodulation therapy comprises a radiofrequency (RF) energy.

57:

• The method of claim 49, wherein the neuromodulation therapy comprises an ultrasound energy.

58:

• The method of claim 49,
• wherein the neuromodulation element is disposed on a distal portion of an elongate body of a catheter, and
• wherein advancing the neuromodulation element through the blood vessel to the target location comprises advancing the distal portion of the elongate body through the blood vessel until the neuromodulation element is at the target location.

60:

• The system of claim 59, wherein the one or more conditions are associated with systemic sympathetic hyperactivity of the patient, and wherein the neuromodulation energy is configured to reduce the systemic sympathetic hyperactivity.

61:

• The system of claim 59, wherein the one or more conditions are associated with central sympathetic overactivity of the patient, and wherein the neuromodulation energy is configured to reduce the central sympathetic overactivity.

63:

• The system of claim 59, wherein the one or more nerves innervate the sex organs or genitalia.

64:

• The system of claim 59, wherein the blood vessel is an inferior mesenteric artery of the patient.

65:

• The system of claim 59, wherein the neuromodulation therapy comprises a radiofrequency (RF) energy.

66:

• The system of claim 59, wherein the neuromodulation therapy comprises an ultrasound energy.